Calcimedica推进资金支持Auxora 1B期PAH研究及CM5480新药申请,数据预计2027年中公布

美股速递
Jun 24

Calcimedica宣布,所获资金将用于支持其候选药物Auxora在肺动脉高压(PAH)领域的1B期临床研究,以及另一款在研药物CM5480的新药临床试验申请(IND)准备工作。

公司预计,这两项研究的关键数据有望在2027年中期获得。此举标志着Calcimedica在推进其创新疗法管线方面取得了重要进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10